Results 1 to 10 of about 1,870 (202)

Patient Perceptions and Type 1 Delay in Head and Neck Cancer: A Scoping Review of High- and Low-/Middle-Income Countries. [PDF]

Laryngoscope Investig Otolaryngol
ABSTRACT Objective To identify and compare how patient perceptions contribute to Type 1 Delays, defined as delays in deciding to seek care, among individuals with head and neck cancer (HNC) in high‐income countries (HICs) and low‐ and middle‐income countries (LMICs).
Anderson MA, Mayes C, Desai A, Polen K, Black JL, Reitz I, Taengwa G, Buhwa G, Chacon J, Davide A, Wiedermann JP.   +10 more
europepmc   +2 more sources

DNA Virus Detection in Olfactory Neuroblastomas Using Targeted Enrichment NGS. [PDF]

Neuropathology
ABSTRACT A variety of malignancies can be found in the sinonasal tract including the nasal cavity, paranasal sinuses, and skull base. Many of these are attributed to viruses, for example, carcinomas with the presence of transcriptionally active high‐risk human papillomavirus, as well as Epstein–Barr virus associated malignant lymphoepithelial carcinoma
Jauhiainen MK, Mielonen OI, Haapaniemi A, Söderlund-Venermo M, Hagström J, Perdomo MF, Sinkkonen ST, Mäkitie AA.   +7 more
europepmc   +2 more sources

Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors. [PDF]

Cancers (Basel)
Simple Summary Therapy in esthesioneuroblastoma (ENB) involves complete surgical resection with or without adjuvant therapy. Complete resection can be achieved by various surgical methods including various open approaches (OpS) and endoscopic-controlled ...
Koch M, Balk M, Schlaffer S, Agaimy A, Iro H, Mueller SK.   +5 more
europepmc   +2 more sources

Neoadjuvant Chemotherapy-Induced Downstaging Enables R0 Craniofacial Combined Resection in AJCC (American Joint Committee on Cancer) Stage IV Olfactory Neuroblastoma: A Case Report of 12-Year Disease-Free Survival. [PDF]

Cureus
Nakazono A.
europepmc   +1 more source

Endoscopic surgery versus various open approaches in esthesioneuroblastoma: a systematic review of the literature. [PDF]

Front Oncol
Koch M, Balk M, Schlaffer S, Allner M, Iro H, Müller SK.   +5 more
europepmc   +1 more source

Isocitrate Dehydrogenase 2 (IDH2)-Mutant Metastatic Esthesioneuroblastoma: A Case Report and Review of Current Therapeutic Options. [PDF]

Cureus
Banha R, Fernandes R, Floudas CS, Vieira C.   +3 more
europepmc   +1 more source

Surgical Management of Esthesioneuroblastoma at a Single Tertiary Care Center. [PDF]

J Neurol Surg B Skull Base
Patel EJ, Glastonbury C, Zante AV, Yom SS, McDermott M, Theodosopoulos P, Aghi M, Goldschmidt E, El-Sayed I.   +8 more
europepmc   +1 more source

Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma. [PDF]

Clin Nucl Med
Zhi Y, Serfling SE, Groener D, Hartrampf PE, Higuchi T, Scheich M, Hackenberg S, Buck AK, Steinbach JP, Werner RA, Klimek K, Augustin M.   +11 more
europepmc   +1 more source

Esthesioneuroblastoma [PDF]

, 2020
openaire   +1 more source

Characterization of Sinonasal Lesions on CT, MRI, and PET/CT. [PDF]

Clin Nucl Med
Wang J, Kuker RA, Yu JQM, Jain N, McKinney AM, Quencer RM.   +5 more
europepmc   +1 more source